Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Infinity Pharmaceuti (INFI)

1.17   0.01 (0.86%) 08-13 16:00
Open: 1.15 Pre. Close: 1.16
High: 1.18 Low: 1.09
Volume: 819,582 Market Cap: 69M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. It offers IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the enzyme phosphoinositide-3-kinase-gamma Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib, as well as duvelisib program for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma; and PellePharm, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.181 - 1.186 1.186 - 1.192
Low: 1.076 - 1.083 1.083 - 1.088
Close: 1.159 - 1.17 1.17 - 1.179

Technical analysis

as of: 2020-08-13 4:35:23 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.45     One year: 1.69
Support: Support1: 0.96    Support2: 0.78
Resistance: Resistance1: 1.24    Resistance2: 1.45
Pivot: 0.97
Moving Average: MA(5): 1.11     MA(20): 0.94
MA(100): 0.94     MA(250): 1.06
MACD: MACD(12,26): 0.06     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 82.54     %D(3): 83.68
RSI: RSI(14): 72.05
52-week: High: 1.68  Low: 0.60  Change(%): -4.1
Average Vol(K): 3-Month: 73811  10-Days: 106269

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
INFI has closed below upper band by 9.3%. Bollinger Bands are 102.9% wider than normal. The large width of the bands suggest high volatility as compared to INFI's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Wed, 12 Aug 2020
Stocks To Watch: Infinity Pharmaceuticals, Inc. (INFI) Is Creating Trading Opportunities - Invest Million

Wed, 12 Aug 2020
The Forecast Just Changed on Infinity Pharmaceuticals Inc. (NASDAQ:INFI) - The Oracle Dispatch

Tue, 11 Aug 2020
An in-depth look at the Infinity Pharmaceuticals, Inc. (INFI) stock - Marketing Sentinel

Tue, 11 Aug 2020
How Much Is Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Paying Its CEO? - Yahoo Finance

Tue, 11 Aug 2020
Infinity Pharmaceuticals (NASDAQ:INFI) Will Have To Spend Its Cash Wisely - Yahoo Finance

Thu, 06 Aug 2020
How Much Is Infinity Pharmaceuticals’ (NASDAQ:INFI) CEO Getting Paid? - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 57
Shares Float (M) 38
% Held by Insiders 3.51
% Held by Institutions 50.64
Shares Short (K) 47
Shares Short P. Month (K) 36

Stock Financials

EPS -0.774
EPS Est This Year -0.920
EPS Est Next Year -1.500
Book Value (p.s.) -0.040
Profit Margin
Operating Margin -3174.61
Return on Assets (ttm) -40.2
Return on Equity (ttm) -237.9
Qtrly Rev. Growth -80.0
Gross Profit (p.s.) -0.546
Sales Per Share 0.023
EBITDA (p.s.) -0.732
Qtrly Earnings Growth
Operating Cash Flow (M) -38
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -1.51
PEG Ratio
Price to Book value -29.25
Price to Sales 50.52
Price to Cash Flow -1.79

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.